Biomark Diagnostics Inc

NEW
FRA:20B (Canada)  
€ 0.28 (0%) Sep 14
At Loss
P/B:
98.00
Market Cap:
€ 32.45M ($ 37.45M)
Enterprise V:
€ 32.75M ($ 37.80M)
Volume:
0
Avg Vol (2M):
1.50K
Trade In:

Biomark Diagnostics Inc (FRA:20B) Dividend

Biomark Diagnostics Inc (FRA:20B) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -8.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: FRA:20B Dividend

Does Biomark Diagnostics Inc (FRA:20B) pay a dividend?

Biomark Diagnostics Inc (FRA:20B) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Biomark Diagnostics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Biomark Diagnostics Inc has returned capital to shareholders via buybacks at a rate of -8.1% over the past 3 years.

What are dividend-paying alternatives to Biomark Diagnostics Inc?

For dividend-paying alternatives in Biomark Diagnostics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.